A cell-based screen for drugs to treat Huntington's disease by Charity T Aiken, Allan J Tobin, Erik S Schweitzer

Get full text

Forecasting individual progression trajectories in Huntington disease enables more powered clinical trials by Igor Koval, Thomas Dighiero-Brecht, Allan J. Tobin, Sarah J. Tabrizi, Rachael I. Scahill, Sophie Tezenas du Montcel, Stanley Durrleman, Alexandra Durr

Get full text

Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline. by Liliana B Menalled, Monica Patry, Natalie Ragland, Phillip A S Lowden, Jennifer Goodman, Jennie Minnich, Benjamin Zahasky, Larry Park, Janet Leeds, David Howland, Ethan Signer, Allan J Tobin, Daniela Brunner

Get full text